199 related articles for article (PubMed ID: 27852142)
1. EBV-positive Richter's syndrome with laboratory features of Burkitt's lymphoma, in Ibrutinib-treated chronic lymphocytic leukemia.
Hussaini MO; Rehman A; Chavez JC; Pinilla-Ibarz J; Horna P
Leuk Lymphoma; 2017 Jul; 58(7):1753-1756. PubMed ID: 27852142
[No Abstract] [Full Text] [Related]
2. Epstein-Barr virus infection in Richter's transformation.
Ansell SM; Li CY; Lloyd RV; Phyliky RL
Am J Hematol; 1999 Feb; 60(2):99-104. PubMed ID: 9929100
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin Lymphoma Transformation of Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: Chance Association or Therapy-related?
Sachanas S; Pangalis GA; Moschogiannis M; Yiakoumis X; Koulieris E; Tsirkinidis P; Kalpadakis C; Rontogianni D
Anticancer Res; 2017 Jun; 37(6):3277-3280. PubMed ID: 28551676
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
[TBL] [Abstract][Full Text] [Related]
5. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.
Younes A; Brody J; Carpio C; Lopez-Guillermo A; Ben-Yehuda D; Ferhanoglu B; Nagler A; Ozcan M; Avivi I; Bosch F; Caballero Barrigón MD; Hellmann A; Kuss B; Ma DDF; Demirkan F; Yağci M; Horowitz NA; Marlton P; Cordoba R; Wrobel T; Buglio D; Streit M; Hodkinson BP; Schaffer M; Alvarez J; Ceulemans R; Balasubramanian S; de Jong J; Wang SS; Fourneau N; Jurczak W
Lancet Haematol; 2019 Feb; 6(2):e67-e78. PubMed ID: 30642819
[TBL] [Abstract][Full Text] [Related]
6. Remineralization of lytic bone disease in a patient with small lymphocytic lymphoma using ibrutinib.
Tucker DL; Mihailescu L; Riordan R; Rule S
Br J Haematol; 2017 Jul; 178(1):153-155. PubMed ID: 27172457
[No Abstract] [Full Text] [Related]
7. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
8. Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection.
de Leval L; Vivario M; De Prijck B; Zhou Y; Boniver J; Harris NL; Isaacson P; Du MQ
Am J Surg Pathol; 2004 May; 28(5):679-86. PubMed ID: 15105659
[TBL] [Abstract][Full Text] [Related]
9. EBV negative Richter's syndrome from a coexistent clone after salvage treatment with alemtuzumab in a CLL patient.
Janssens A; Berth M; De Paepe P; Verhasselt B; Van Roy N; Noens L; Philippé J; Offner F
Am J Hematol; 2006 Sep; 81(9):706-12. PubMed ID: 16838338
[TBL] [Abstract][Full Text] [Related]
10. Concomitant Epstein-Barr virus-negative large B-cell lymphoma (Richter syndrome) and Epstein-Barr virus- positive B-cell lymphoproliferation after treatment with fludarabine and cyclophosphamide in a patient with B-cell chronic lymphocytic leukemia.
Compérat E; Delmer A; Le Tourneau A; Molina TJ; Diebold J; Audouin J
Arch Pathol Lab Med; 2006 Aug; 130(8):1227-30. PubMed ID: 16879030
[TBL] [Abstract][Full Text] [Related]
11. Ibrutinib has some activity in Richter's syndrome.
Giri S; Hahn A; Yaghmour G; Martin MG
Blood Cancer J; 2015 Jan; 5(1):e277. PubMed ID: 25635530
[No Abstract] [Full Text] [Related]
12. Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome.
Fischer A; Bastian S; Cogliatti S; Mey U; Saub J; Schanz U; Padberg B; Hohloch K
Hematol Oncol; 2018 Feb; 36(1):370-371. PubMed ID: 28681549
[No Abstract] [Full Text] [Related]
13. Richter's syndrome--the downside of fludarabine?
Hamblin TJ
Leuk Res; 2005 Oct; 29(10):1103-4. PubMed ID: 16111529
[No Abstract] [Full Text] [Related]
14. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
15. Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.
Niemann CU; Herman SE; Maric I; Gomez-Rodriguez J; Biancotto A; Chang BY; Martyr S; Stetler-Stevenson M; Yuan CM; Calvo KR; Braylan RC; Valdez J; Lee YS; Wong DH; Jones J; Sun C; Marti GE; Farooqui MZ; Wiestner A
Clin Cancer Res; 2016 Apr; 22(7):1572-82. PubMed ID: 26660519
[TBL] [Abstract][Full Text] [Related]
16. Ibrutinib-Induced Lymphocytosis: Cytological Features.
Quintela A; Sujobert P; Callet-Bauchu E; Salles G; Baseggio L
Acta Haematol; 2017; 137(1):55-57. PubMed ID: 27960168
[No Abstract] [Full Text] [Related]
17. Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.
Syrjänen S; Kallio P; Sainio P; Fuju C; Syrjänen K
Scand J Dent Res; 1992 Jun; 100(3):176-80. PubMed ID: 1321486
[TBL] [Abstract][Full Text] [Related]
18. Ibrutinib for Chronic Lymphocytic Leukemia with
Ahn IE; Tian X; Wiestner A
N Engl J Med; 2020 Jul; 383(5):498-500. PubMed ID: 32726539
[No Abstract] [Full Text] [Related]
19. Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature.
Granai M; Ambrosio MR; Akarca A; Mundo L; Vergoni F; Santi R; Mancini V; di Stefano G; Amato T; Bellan C; Puccini B; Sorrentino E; Naresh KN; Leoncini L; Marafioti T; Lazzi S
Haematologica; 2019 Jun; 104(6):e269-e273. PubMed ID: 30846502
[No Abstract] [Full Text] [Related]
20. CLL progression after one cycle of FCR: Richter's transformation versus EBV-associated lympho-proliferation.
Jain P; Burger JA; Khoury JD
Am J Hematol; 2017 Oct; 92(10):1113-1114. PubMed ID: 28670739
[No Abstract] [Full Text] [Related]
[Next] [New Search]
